Jim Simons’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.28M | Sell |
502,217
-13,500
| -3% | -$157K | 0.01% | 1154 |
|
|
2025
Q4 | $4.96M | Sell |
515,717
-17,300
| -3% | -$166K | 0.01% | 1308 |
|
|
2025
Q3 | $5.01M | Buy |
533,017
+5,800
| +1% | +$55.4K | 0.01% | 1494 |
|
|
2025
Q2 | $5.58M | Sell |
527,217
-1,400
| -0.3% | -$17.7K | 0.01% | 1457 |
|
|
2025
Q1 | $7.95M | Buy |
528,617
+100
| +0% | +$1.66K | 0.01% | 1133 |
|
|
2024
Q4 | $8.7M | Sell |
528,517
-45,712
| -8% | -$902K | 0.01% | 1106 |
|
|
2024
Q3 | $14.2M | Sell |
574,229
-24,000
| -4% | -$622K | 0.02% | 859 |
|
|
2024
Q2 | $15.2M | Buy |
598,229
+38,412
| +7% | +$996K | 0.03% | 719 |
|
|
2024
Q1 | $14.2M | Sell |
559,817
-4,512
| -0.8% | -$109K | 0.02% | 807 |
|
|
2023
Q4 | $12.8M | Sell |
564,329
-24,300
| -4% | -$503K | 0.02% | 829 |
|
|
2023
Q3 | $11M | Sell |
588,629
-44,600
| -7% | -$925K | 0.02% | 871 |
|
|
2023
Q2 | $16.5M | Buy |
633,229
+57,812
| +10% | +$1.55M | 0.02% | 767 |
|
|
2023
Q1 | $16.5M | Sell |
575,417
-20,112
| -3% | -$599K | 0.02% | 825 |
|
|
2022
Q4 | $17.6M | Sell |
595,529
-40,988
| -6% | -$1.17M | 0.02% | 776 |
|
|
2022
Q3 | $15.1M | Sell |
636,517
-69,300
| -10% | -$1.59M | 0.02% | 815 |
|
|
2022
Q2 | $15.8M | Buy |
705,817
+29,600
| +4% | +$660K | 0.02% | 856 |
|
|
2022
Q1 | $17M | Sell |
676,217
-7,200
| -1% | -$220K | 0.02% | 854 |
|
|
2021
Q4 | $24.5M | Sell |
683,417
-20,600
| -3% | -$825K | 0.03% | 614 |
|
|
2021
Q3 | $30M | Sell |
704,017
-14,700
| -2% | -$605K | 0.04% | 489 |
|
|
2021
Q2 | $31.1M | Sell |
718,717
-26,300
| -4% | -$1.12M | 0.04% | 512 |
|
|
2021
Q1 | $30.4M | Sell |
745,017
-64,100
| -8% | -$2.43M | 0.04% | 554 |
|
|
2020
Q4 | $36.6M | Sell |
809,117
-27,400
| -3% | -$1.04M | 0.04% | 470 |
|
|
2020
Q3 | $29.6M | Buy |
836,517
+1,600
| +0.2% | +$57.8K | 0.03% | 566 |
|
|
2020
Q2 | $31.5M | Buy |
834,917
+87,088
| +12% | +$2.87M | 0.03% | 584 |
|
|
2020
Q1 | $21.6M | Buy |
747,829
+162,700
| +28% | +$6.58M | 0.02% | 727 |
|
|
2019
Q4 | $30.3M | Buy |
585,129
+102,207
| +21% | +$5.94M | 0.02% | 772 |
|
|
2019
Q3 | $26.5M | Buy |
482,922
+38,700
| +9% | +$1.99M | 0.02% | 806 |
|
|
2019
Q2 | $18M | Buy |
444,222
+78,812
| +22% | +$2.87M | 0.02% | 1023 |
|
|
2019
Q1 | $11.1M | Buy |
365,410
+102,277
| +39% | +$3.5M | 0.01% | 1319 |
|
|
2018
Q4 | $8.84M | Sell |
263,133
-6,993
| -3% | -$252K | 0.01% | 1383 |
|
|
2018
Q3 | $11.4M | Sell |
270,126
-47,374
| -15% | -$1.87M | 0.01% | 1274 |
|
|
2018
Q2 | $10.2M | Buy |
317,500
+115,400
| +57% | +$4.75M | 0.01% | 1333 |
|
|
2018
Q1 | $10M | Buy |
202,100
+92,400
| +84% | +$5.22M | 0.01% | 1367 |
|
|
2017
Q4 | $5.91M | Sell |
109,700
-5,000
| -4% | -$277K | 0.01% | 1701 |
|
|
2017
Q3 | $6.65M | Sell |
114,700
-30,200
| -21% | -$1.58M | 0.01% | 1574 |
|
|
2017
Q2 | $7.15M | Sell |
144,900
-108,200
| -43% | -$4.98M | 0.01% | 1470 |
|
|
2017
Q1 | $11M | Buy |
253,100
+86,300
| +52% | +$4.12M | 0.02% | 1169 |
|
|
2016
Q4 | $8.17M | Sell |
166,800
-40,900
| -20% | -$1.89M | 0.01% | 1369 |
|
|
2016
Q3 | $9.94M | Sell |
207,700
-63,400
| -23% | -$3.13M | 0.02% | 1154 |
|
|
2016
Q2 | $14.5M | Sell |
271,100
-29,300
| -10% | -$1.38M | 0.03% | 902 |
|
|
2016
Q1 | $13.4M | Buy |
300,400
+187,400
| +166% | +$7.6M | 0.03% | 928 |
|
|
2015
Q4 | $4.31M | Buy |
113,000
+59,400
| +111% | +$2.27M | 0.01% | 1598 |
|
|
2015
Q3 | $1.71M | Sell |
53,600
-63,600
| -54% | -$2.22M | ﹤0.01% | 2098 |
|
|
2015
Q2 | $3.87M | Buy |
117,200
+4,700
| +4% | +$168K | 0.01% | 1611 |
|
|
2015
Q1 | $4.63M | Sell |
112,500
-100,300
| -47% | -$4.05M | 0.01% | 1421 |
|
|
2014
Q4 | $8.67M | Sell |
212,800
-57,800
| -21% | -$2.26M | 0.02% | 959 |
|
|
2014
Q3 | $9.92M | Sell |
270,600
-96,800
| -26% | -$4.18M | 0.03% | 760 |
|
|
2014
Q2 | $17M | Sell |
367,400
-75,000
| -17% | -$3.34M | 0.04% | 557 |
|
|
2014
Q1 | $18.2M | Buy |
442,400
+45,600
| +11% | +$1.69M | 0.04% | 524 |
|
|
2013
Q4 | $15.1M | Sell |
396,800
-5,300
| -1% | -$164K | 0.04% | 599 |
|
|
2013
Q3 | $9.61M | Buy |
402,100
+31,397
| +8% | +$705K | 0.02% | 824 |
|
|
2013
Q2 | $6.3M | Buy |
+370,703
| New | +$5.35M | 0.02% | 969 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
Jim Simons's ANIK Position: Q1 2026 in Review
Jim Simons reduced its Anika Therapeutics (ANIK) stake by 2.6% in Q1 2026, selling an estimated $157K and leaving 502,217 shares worth $7.28M. The position accounts for 0.01% of the portfolio, ranked #1154.
Jim Simons first reported a position in ANIK in Q2 2013 and has held it in 52 quarters since. The position peaked at $36.6M in Q4 2020. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.
- Jim Simons held 502,217 shares of Anika Therapeutics worth $7.28M as of Q1 2026.
- Jim Simons sold 13,500 Anika Therapeutics shares in Q1 2026, an estimated $157K.
- Anika Therapeutics made up 0.01% of Jim Simons's portfolio in Q1 2026, its #1154 holding.
- Jim Simons first reported a position in Anika Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Jim Simons's Anika Therapeutics position peaked at $36.6M in Q4 2020.
- 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.